Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Class C1 decoy oligodeoxynucleotide inhibits profibrotic genes expression in rat hepatic stellate cells.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: D. A. Spandidos Country of Publication: Greece NLM ID: 101475259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-3004 (Electronic) Linking ISSN: 17912997 NLM ISO Abbreviation: Mol Med Rep Subsets: MEDLINE
- Publication Information:
Original Publication: Athens, Greece : D. A. Spandidos
- Subject Terms:
- Abstract:
The aim of the present study was to investigate whether class C1 decoy oligodeoxynucleotides (ODNs) can inhibit the expression of pro‑fibrotic genes associated with rat hepatic stellate cell (HSC) activation and hepatic fibrosis. Luciferase reporter assays were performed to test the promoter activities of transforming growth factor (TGF)‑β and its downstream target genes following transfection of decoy ODNs and plasmids into HSC‑T6 cells, and western blot assays were performed to measure the protein expression of those genes following decoy ODN transfection. Class C1 decoy ODNs were confirmed to inhibit the promoter activity of TGF‑β and its downstream target genes, such as type 1 collagen (COLI)α1, tissue inhibitor of metalloproteinases (TIMP)1 and α‑smooth muscle actin by Gaussia luciferase reporter assay, and to further downregulate the expression of TGF‑β, SMAD3, COLIα1 and TIMP1 by western blotting in activated HSC‑T6 cells. In conclusion, class C1 decoy ODNs inhibited pro‑fibrotic gene expression in rat HSCS by downregulating TGF‑β signaling.
- References:
Hepatogastroenterology. 2012 Sep;59(118):1960-3. (PMID: 22369740)
Curr Drug Targets. 2003 Nov;4(8):603-8. (PMID: 14577649)
Arch Biochem Biophys. 2014 Apr 15;548:20-37. (PMID: 24631571)
Cancers (Basel). 2014 Jun 27;6(3):1220-55. (PMID: 24978432)
Life Sci. 2018 Jan 1;192:221-230. (PMID: 29154784)
J Diabetes Res. 2013;2013:979702. (PMID: 23691527)
Biochem Biophys Res Commun. 2015 Aug 7;463(4):853-8. (PMID: 26051274)
Curr Drug Targets. 2003 May;4(4):339-46. (PMID: 12699354)
Cell Biosci. 2016 May 10;6:31. (PMID: 27175276)
Cell. 1994 May 6;77(3):451-9. (PMID: 8181063)
Curr Top Dev Biol. 2014;110:263-83. (PMID: 25248479)
Exp Biol Med (Maywood). 2014 Dec;239(12):1589-96. (PMID: 25107895)
Cell Physiol Biochem. 2015;35(6):2233-43. (PMID: 25895516)
World J Gastroenterol. 2015 Jan 21;21(3):878-87. (PMID: 25624721)
J Cell Physiol. 2003 Mar;194(3):237-55. (PMID: 12548545)
Nat Rev Gastroenterol Hepatol. 2016 Feb;13(2):67-8. (PMID: 26758787)
Annu Rev Pathol. 2011;6:425-56. (PMID: 21073339)
J Cell Biol. 2003 Nov 24;163(4):723-8. (PMID: 14638857)
Cell. 2008 Aug 22;134(4):657-67. (PMID: 18724938)
Int J Oncol. 2014 Oct;45(4):1363-71. (PMID: 25050845)
Zhonghua Gan Zang Bing Za Zhi. 2012 Sep;20(9):677-82. (PMID: 23207232)
J Hepatol. 2015 Oct;63(4):1038-9. (PMID: 26232376)
World J Gastroenterol. 2017 Apr 7;23(13):2330-2336. (PMID: 28428712)
- Contributed Indexing:
Keywords: class c1 decoy oligodeoxynucleotides; transforming growth factor-β signaling; hepatic stellate cells
- Accession Number:
0 (Collagen Type I)
0 (Hes1 protein, rat)
0 (Oligodeoxyribonucleotides)
0 (Smad3 Protein)
0 (Tissue Inhibitor of Metalloproteinase-1)
0 (Transcription Factor HES-1)
0 (Transforming Growth Factor beta)
- Publication Date:
Date Created: 20200125 Date Completed: 20201006 Latest Revision: 20210917
- Publication Date:
20240829
- Accession Number:
PMC6947877
- Accession Number:
10.3892/mmr.2019.10881
- Accession Number:
31974596
No Comments.